ShiLai™ Healthcare Team Shares Their Favorite Product Packaging of 2025
As we look back on 2025, one thing has become clear inside ShiLai™ Healthcare:
this was the year our product packaging finally caught up with our ambitions.
During a recent internal discussion involving our R&D, manufacturing, quality, and commercial teams, a simple question was raised:
“Which 2025 product packaging are you most proud of?”
The answer came quickly—and repeatedly.
So did one recurring comment:
“We honestly wish these had launched in 2024.”
Not because they were late—but because, by the time they reached the market, they already felt fully realized.
Below are the product packaging designs most frequently highlighted by our team as standouts of 2025.
⭐ Retatrutide 40mg Pen
High-dose, refined, and unmistakably professional
The Retatrutide 40mg Pen quickly became a favorite across departments.
- High-dose configuration designed for professional and research use
- Clean, restrained pen aesthetics aligned with clinical environments
- Clear labeling, batch traceability, and packaging logic
Several team members described it as “the first Retatrutide pen that feels complete in every detail.”
⭐ BPC-157 & TB-500 20mg Pen
A classic combination, executed the right way
This dual-peptide pen was praised for its practicality and clarity.
- Two commonly paired peptides delivered in a single pen
- Simplified handling and inventory management
- Straightforward composition presentation with no visual clutter
From a commercial perspective, it significantly improved communication efficiency with professional buyers.
⭐ Glow Blend 70 mg Pen
(GHK-Cu 50 mg · BPC-157 10 mg · TB-500 10 mg)
A benchmark for multi-compound formulation design
Glow Blend stood out as one of the most visually and structurally refined products of the year.
- Complex formulation presented with exceptional clarity
- Balanced information density without overwhelming the user
- Strong alignment between formulation logic and packaging design
As one R&D colleague put it:
“This is what happens when formulation and packaging are designed together—not separately.”
⭐ NAD⁺ 1000mg Pen
Standardizing a complex, high-content product
High-dose NAD⁺ presents unique challenges, and this pen became an internal reference point for how to solve them.
- 1000mg specification handled with consistency and stability in mind
- Minimalist, professional appearance—no unnecessary branding noise
- Well-suited for institutional, clinical, and B2B environments
Quality and logistics teams especially noted its reliability during storage and transport.
⭐ GHK-Cu 40mg Pen
Where professionalism shows at first glance
The GHK-Cu 40mg Pen received some of the most consistent praise.
- Restrained color palette and disciplined layout
- Clear positioning for research and professional use
- Visual language fully aligned with the ShiLai™ pen portfolio
One internal comment summed it up perfectly:
“This is a product you wouldn’t hesitate to place directly on a lab bench.”
Looking Ahead
Although these products officially launched in 2025, they represent far more than a single year of work.
They are the result of repeated testing, redesign, and internal debate—often starting over to get it right.
When our team says “we wish these had launched in 2024,”
what they really mean is this:
By the time they reached the market, they were already ready.
2026 was a milestone—but not the destination.
ShiLai™ Healthcare will continue refining both product performance and packaging systems with the same discipline moving forward.
Because real confidence starts inside the company—long before it reaches the market.